ZEB1 deficient pancreatic cancer cell lines are incapable of compensatory increasing glycolysis when oxidative phosphorylation is blocked, highlighting poor glycolytic reserve (Krebs et al, 2017). Here, ZEB1 is linked to familial pancreatic carcinoma.